Letter: psoriasiform eruption during vedolizumab therapy

Aliment Pharmacol Ther. 2019 Aug;50(3):342-343. doi: 10.1111/apt.15389.

Authors

Giuseppe Maria Garbo¹, Sara Renna¹, Valentina Caputo², Elisabetta Orlando³, Fabio Salvatore Macaluso¹, Rosalba Orlando¹, Maria Rita Bongiorno², Ambrogio Orlando¹

Affiliations

¹ IBD Unit, Villa Sofia Cervello Hospital, Palermo, Italy.
² Department of Pro.M.I.S.E. "Giuseppe D'Alessandro," Section of Dermatology, University of Palermo, AOUP Paolo Giaccone, Palermo, PA, Italy.
³ Department of Pro.M.I.S.E. "Giuseppe D'Alessandro," Section of Pathology, University of Palermo, AOUP Paolo Giaccone, Palermo, PA, Italy.

PMID: 31313356
DOI: 10.1111/apt.15389

No abstract available

Publication types

Letter
Comment

MeSH terms

Antibodies, Monoclonal, Humanized
Humans
Inflammatory Bowel Diseases*
Psoriasis*
Registries

Substances

Antibodies, Monoclonal, Humanized
vedolizumab